Areas of Focus:

Biomarker DiscoveryClinical TrialsCollaboration & InnovationCross-institutional CollaborationDisease SubtypingEarly Disease DetectionHealth DisparitiesImplementation SciencePatient Engagement & Co-designPatient-reported OutcomesPopulation & Patient-CenteredPrecision MedicineRegulatory ScienceTranslational & ClinicalCross-Cutting & Special PopulationsOtherOverlap Syndromes
  • Associate Professor, Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania

Dr. Benjamin Abramoff is an Assistant Professor of Physical Medicine and Rehabilitation at the Perelman School of Medicine, University of Pennsylvania, where he is the founder and director of Penn Medicine’s Post-COVID Assessment and Recovery Clinic — one of the first comprehensive Long COVID clinics in the country, having treated over 1,500 patients with persistent post-infection symptoms. He also serves as Director of Spinal Cord Injury Services at Penn Rehabilitation.

A nationally recognized expert in Long COVID, Dr. Abramoff authored the widely referenced UpToDate Post-COVID Guidelines and co-chairs the AAPM&R Post-COVID Clinic Collaborative, a network of over 35 clinics nationwide through which he has developed multiple consensus guidance statements on Long COVID management. He has advised the Biden Administration, the CDC, the NIH, and the National Council on Disability on post-COVID issues.

Dr. Abramoff received his undergraduate degree from Cornell University and his MD and concurrent master’s degree in Health and Rehabilitation Sciences from the Ohio State University College of Medicine. He completed his residency in physical medicine and rehabilitation at Emory University and subspecialty training in spinal cord injury medicine at the Shirley Ryan Ability Lab at Northwestern University.

Projects

Featured Pilot Projects

Autoantibodies in Long COVID
Project | University of Pennsylvania

Autoantibodies in Long COVID

Investigating the autoimmune and immune dysregulation mechanisms underlying Long COVID to improve diagnosis, treatment, and biological understanding of persistent symptoms.